Clinical Trials Logo

Clinical Trial Summary

The aim of the clinical trial is to investigate whether the use of a new multichannel endoscopic transanal access device (named UNI-VEC) is safe and effective in the resection of a rectal polyp or tumor that sits in the distal part of the colon (up to about 20 cm from the anal margin). This is the first study to test the device in humans, after proving its good performance in preclinical development (preclinical development has included functional laboratory tests and an animal trial).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06286956
Study type Interventional
Source Vecmedical Spain, S.L.
Contact Ariadna Camps, Biomedical engineering
Phone +34 935725015
Email ariadna.camps@vecmedical.com
Status Recruiting
Phase N/A
Start date April 19, 2021
Completion date September 7, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Terminated NCT04977401 - EndoscoPic Submucosal dIssection Using geL Versus glycerOl for Submucosal iNjection N/A
Active, not recruiting NCT04651764 - Transanal Resection of Rectal Lesions With the ColubrisMX ELS System N/A
Not yet recruiting NCT05776381 - The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp Phase 2
Enrolling by invitation NCT03700593 - Feasibility and Safety of Single Port Robot in Colorectal Procedures
Active, not recruiting NCT04889352 - Optimizing Timing of Follow-up Colonoscopy N/A
Not yet recruiting NCT02579330 - Trial on Use of Coloshield in Transanal and Anal Surgery N/A